Monica Moya | 19-LW-006
Executive Summary
We will develop a novel platform for testing endovascular treatments that includes a bioprinted device that will model aneurysms using living cells and a powerful computational model for the prediction of aneurysm treatment outcomes. The ability to model, predict, and test personalized aneurysm treatments supports national biosecurity efforts and offers an adaptable framework for a broad array of personalized surgical intervention techniques.
Publications, Presentations, and Patents
Moya, M. L. 2020a. "Three-Dimensional Bioprinting of Aneurysm-Bearing Tissue Structure of Embolization Coils." Biomedical Engineering Society Conference (virtual), October 2020. LLNL-PRES-814987
——— 2020b. "Three-Dimensional Bioprinting of Aneurysm-Bearing Tissue Structure with Deployment of Embolization Coils," Biofabrication 13. LLNL-JRNL-807798
——— 2020c. "Tissue Structure with Deployment of Embolization Coils Three-Dimensional Bioprinting of Aneurysm-Bearing." Biomedical Engineering Society. LLNL-ABS-810438
